Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
237.45
+7.90 (3.44%)
At close: May 19, 2026, 4:00 PM EDT
238.57
+1.12 (0.47%)
After-hours: May 19, 2026, 7:50 PM EDT

Jazz Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
14,89810,4447,4677,65710,0717,852
Market Cap Growth
104.34%39.87%-2.49%-23.96%28.26%-15.31%
Enterprise Value
17,44112,38110,5907,65710,0717,852
Last Close Price
237.45170.00123.15123.00159.31127.40
PE Ratio
505.85-14.2420.16--
Forward PE
9.747.675.726.298.548.23
PEG Ratio
0.180.550.370.501.140.62
PS Ratio
3.362.451.842.00--
PB Ratio
3.282.421.82---
P/TBV Ratio
3.312.401.99---
P/FCF Ratio
11.738.055.507.17--
P/OCF Ratio
11.177.705.357.01--
EV/Sales Ratio
3.932.902.602.00--
EV/EBITDA Ratio
8.6846.547.696.29--
EV/EBIT Ratio
13.46-14.7813.23--
EV/FCF Ratio
13.749.557.807.17--
Debt / Equity Ratio
0.961.011.49---
Debt / EBITDA Ratio
12.5820.334.47---
Debt / FCF Ratio
4.264.174.53---
Net Debt / Equity Ratio
0.560.690.77---
Net Debt / EBITDA Ratio
5.8911.152.29---
Net Debt / FCF Ratio
1.992.292.32---
Asset Turnover
0.380.360.68---
Inventory Turnover
1.251.121.86---
Quick Ratio
1.651.463.57---
Current Ratio
2.041.864.46---
Return on Equity (ROE)
0.67%-8.47%27.36%---
Return on Assets (ROA)
0.33%-2.06%14.25%---
Return on Invested Capital (ROIC)
0.48%-3.03%21.32%---
Return on Capital Employed (ROCE)
-2.98%-4.22%13.06%---
Earnings Yield
0.20%-7.02%4.96%0.00%0.00%
FCF Yield
8.52%12.42%18.19%13.95%0.00%0.00%
Buyback Yield / Dilution
5.13%7.61%8.41%-14.00%--
Total Shareholder Return
5.13%7.61%8.41%-14.00%--
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q